Wolverine Trading, LLC Adamis Pharmaceuticals Corp Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.24 - $0.54 $2,544 - $5,724	10,600 New	10,600 $2,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $16,115 - $21,389	-29,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $10,886 - $23,493	-19,100 Reduced 39.46%	29,300 $17,000
Q3 2021 Nov 12, 2021	BUY	$0.92 - $1.18 $44,528 - $57,112	48,400 New	48,400 $46,000
Q2 2021 Aug 06, 2021	SELL	$0.66 - $1.23 $28,512 - $53,136	-43,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$0.54 - $1.79 $4,644 - $15,394	8,600 Added 24.86%	43,200 $40,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $21,600 - $46,080	9,600 Added 38.4%	34,600 $121,000
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $69,105 - $131,435	-27,100 Reduced 52.02%	25,000 $88,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $5.65 $234,450 - $294,365	52,100	52,100 $272,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.